Genetic & Genomic MedicineJCO Precision OncologyPeer-reviewed
CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERS
Tyler Shugg, Reynold C. Ly, Elizabeth J. Rowe…·Todd C. Skaar
The paper assesses opportunities for germline pharmacogenetics and drug-drug interaction management in advanced cancer patients using EHR data and CPIC guidelines.
19 citations